ClinicalTrials.Veeva

Menu

Singapore Healthy Alternative Protein Evaluation Study (SHAPES)

C

Clinical Nutrition Research Centre, Singapore

Status

Enrolling

Conditions

Protein Metabolism Disorder
Diabetes Mellitus
Cardiovascular Diseases

Treatments

Dietary Supplement: Animal-based meats
Dietary Supplement: Plant-based meat alternatives

Study type

Interventional

Funder types

Other

Identifiers

NCT05446753
2022/00278

Details and patient eligibility

About

The overall aim of this randomized controlled trial is to investigate the effects of consuming a Plant-Based Meat alternative Diet (PBMD) compared to an Animal-Based Meat Diet (ABMD) on cardiometabolic health and protein homeostasis in Chinese men and women in Singapore. This will be achieved through the following specific objectives: (1) To evaluate the effects of dietary protein source on metabolic health and glycemic control(2) To evaluate the effects of dietary protein source on risk factors of cardiovascular diseases (3) To evaluate the effects of dietary protein source on protein homeostasis and metabolism.

Enrollment

100 estimated patients

Sex

All

Ages

30 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Chinese males and females
  2. Age > 30 to </= 70 years
  3. Habitually consuming between 2 and 4 servings of protein-rich foods daily (~20 g protein per serving)
  4. Raised blood glucose (fasting glucose >/= 5.4 and </= 7.0 mmol/L) and/or (HbA1c >/= 5.7 and </= 6.4 %)
  5. Fully vaccinated against COVID-19 (referred to as having completed a minimum of 2 doses Pfizer-BioNTech / Comirnaty / Moderna or 3 doses Sinovac-CoronaVac)
  6. Ability to give an informed consent
  7. Willing to adhere to study intervention procedures

Exclusion criteria

  1. Obese: BMI (>/= 27.5 kg/m2) and/or waist circumference (>/= 102 cm for male; >/= 88 cm for female)
  2. Significant weight change (± 5 % body weight) during the past 3 months
  3. Past bariatric surgery
  4. Women who are pregnant, lactating or planning pregnancy
  5. History or known present diagnosis of cardiovascular (i.e.hypertension (systolic/diastolic blood pressure: >/= 140/90 mmHg), endocrine (i.e. type 1 and type 2 diabetes mellitus), gastrointestinal, hematological (G6PD and coagulation disorders), hepatic (hepatitis B and C), malignant, renal, respiratory, thyroid or other relevant disorders which may affect the outcomes of interested in consultation with the researchers involved
  6. Prescribed and regularly taking western or traditional medicine which may affect the outcomes of interest in consultation with the researchers involved
  7. History or present diagnosis of HIV and/or tuberculosis.
  8. Drug abuse within the last 5 years
  9. Taking dietary supplements which may affect study outcomes one month prior to their first visit (e.g. protein supplements, omega-3/6 supplements or other nutritional supplements such as Ensure, Anlene etc.)
  10. Following any special diets which may interfere with intervention procedures (for medical, aesthetic or religious reasons)
  11. Allergy to nuts, seeds, legumes (soy, pea), cereal (wheat gluten), beef, pork, chicken or any other ingredients present in foods provided for intervention
  12. Excessive alcoholic beverage consumption > 2 servings per day (1 serving is defined as 360 mL beer, 150 mL wine or 45 mL distilled spirits)
  13. Smoking (cigarette, e-cigarette, cigar, pipe) or vaping
  14. Exercising vigorously over the past 3 months
  15. Staff of Prince September Pte. Ltd. (Pinduoduo Inc.) and/or Singapore Institute of Food and Biotechnology Innovation (SIFBI)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Animal-based meats (ABMD group)
Experimental group
Description:
Participants will be instructed to substitute protein-rich foods consumed habitually with animal-based meats (ABMD group).
Treatment:
Dietary Supplement: Animal-based meats
Plant-based meat alternatives (PBMD group)
Experimental group
Description:
Participants will be instructed to substitute protein-rich foods consumed habitually with Plant-based meat alternatives (PBMD group).
Treatment:
Dietary Supplement: Plant-based meat alternatives

Trial contacts and locations

1

Loading...

Central trial contact

Jeyakumar C Henry, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems